P R Gianello

Plain English
Researchers studied the use of insulin-producing cells from pigs as a potential treatment for people with type 1 diabetes. They found that new pig models genetically modified to reduce immune reactions and improve cell function could lead to safer and more effective transplants, with a lower risk of viral infections. This is important because it could provide a viable alternative for managing diabetes, potentially reducing the need for lifelong insulin therapy. Who this helps: This helps patients with type 1 diabetes seeking better treatment options.

Plain English
The study focused on using islets from pigs as a potential treatment for people with type 1 diabetes. It found promising early results from clinical trials that involved encapsulating these pig islets to protect them from the body's immune system. Researchers are exploring ways to improve this method, such as enhancing insulin production and finding better locations for transplantation, which may lead to more effective treatments for patients. Who this helps: This helps patients with unstable type 1 diabetes.

Plain English
Kidney transplant tolerance induced by a short course of cyclosporine depends on the ongoing presence of donor tissue and on how the immune system recognizes donor antigens. Removing the donor kidney caused tolerance to fade over time, and switching antigen recognition pathways shifted the mechanism of tolerance maintenance. These findings reveal that tolerance is an active, antigen-dependent process rather than a permanent state.

Plain English
This study explored how the thymus, an important organ for the immune system, affects the success of kidney transplants in miniature pigs. Researchers found that having a functioning thymus is crucial during the first eight days after a transplant to help the body accept the new kidney without rejecting it; however, after this period, the thymus is no longer needed to maintain tolerance. Specifically, pigs without a thymus before or right after transplantation showed signs of organ rejection, while those with a thymus had stable organ function. Who this helps: This research helps improve kidney transplant outcomes for patients, particularly children.

Plain English
This study looked at how the thymus gland, which plays a crucial role in the immune system, affects the body's acceptance of kidney transplants in miniature pigs, especially when influenced by steroids and age. Researchers found that young pigs given a steroid along with a transplant drug experienced severe kidney issues but were able to keep their transplanted kidneys for over 100 days, although chronic rejection still occurred. In older pigs, one rejected the kidney quickly, while the other rejected it slowly, showing that both age and steroids can hinder the body's ability to accept transplants. Who this helps: This research benefits doctors and patients undergoing kidney transplants, as it highlights how age and steroid use can impact transplant success.

Plain English
Researchers studied how changes to the thymus affect the acceptance of kidney transplants in miniature pigs. They found that animals undergoing a partial removal of the thymus or multiple biopsies from the thymus had severe problems with their kidney function and rejection of the transplanted kidneys—most developed harmful antibodies against the donor tissue. This is important because it shows that certain surgical procedures on the thymus can prevent the body from accepting donated organs, which is crucial for improving transplant outcomes. Who this helps: This helps patients undergoing organ transplants and their doctors in planning safe surgical strategies.

Plain English
Researchers studied liver transplants between guinea pigs and rats to understand problems with blood flow during the procedure. They found that all transplant cases suffered from poor blood flow to the liver, and while there was no immediate rejection of the graft, the anatomy of the guinea pig's blood vessels made the situation worse. Recognizing these differences is crucial because it helps improve future transplantation efforts and could lead to better transplant outcomes. Who this helps: This helps doctors and researchers working on organ transplants.

Plain English
This study looked at how a short treatment with cyclosporine can help miniature pigs accept transplanted kidneys without rejection. It was found that while both treated and untreated recipients had a similar immune cell response after the transplant, untreated animals rejected the kidney between days 8 and 12, whereas the treated animals showed signs of long-term acceptance. Specifically, animals that accepted the transplant had low levels of a key immune signaling molecule, IFN-gamma, and higher levels of another molecule, IL-10, which suggests a controlled immune response that favors graft survival. Who this helps: This research benefits patients needing kidney transplants by exploring ways to improve transplant acceptance.

Plain English
This study looked at how to successfully transplant kidneys and bone marrow from pigs into monkeys, which is important because it might help in future human transplants. Researchers found that, using a specific treatment, they could keep the monkey recipients' immune responses low for at least 15 days, and one monkey maintained good kidney function during that time, with creatinine levels between 0.8 and 1.3 mg/dl. This matters because it shows progress towards overcoming the challenges of organ rejection in xenotransplantation, which could eventually improve transplant outcomes for patients needing organs. Who this helps: Patients waiting for organ transplants.

Plain English
This study looked at the role of the thymus gland in helping miniature pigs accept transplanted kidneys without rejection. The researchers found that pigs with their thymus removed faced severe rejection of the transplant, while those with an intact thymus had a much milder reaction and accepted the kidney more successfully. This matters because understanding how the thymus helps with organ acceptance can improve transplantation outcomes in humans. Who this helps: This helps patients receiving organ transplants.

Plain English
This study looked at how well matching certain genetic markers (MHC) affects the success of kidney transplants in miniature pigs. Researchers found that when there was at least one matched genetic marker, the chances of the transplant being accepted without rejection were significantly better, especially when both class II markers were matched—resulting in 100% successful acceptance without major kidney issues. This research is important because it suggests that careful genetic matching could make kidney transplants more successful and reduce the need for long-term immunosuppressive medications in humans. Who this helps: This helps patients receiving kidney transplants.

Plain English
This study explored how miniature pigs accepted kidney transplants over the long term after receiving an initial transplant. The researchers found that eight pigs accepted a second kidney transplant from the same donor without needing extra medications to suppress their immune system. This is important because it shows that the first transplant can help the immune system tolerate the second transplant, which could lead to better transplant outcomes in humans. Who this helps: Patients receiving kidney transplants.

Plain English
This study looked at how miniature pigs can accept kidney transplants from donors with different class I proteins in their immune systems, even after their bodies generate an immune response against those proteins. It found that while these pigs don't reject the kidney transplants, they still reject skin grafts from the same donors, which shows that their bodies can differentiate between types of tissues and maintain a form of tolerance for the kidneys. This is important because it reveals how transplant acceptance can occur despite specific immune responses, potentially improving transplant outcomes in humans. Who this helps: This helps patients requiring kidney transplants.

Plain English
This study examined how well a medication called cyclosporine A (CsA) helps prevent rejection of kidney transplants in miniature pigs that share part of their genetic makeup (haplotypes). The researchers found that when CsA was given for 12 days after a transplant, 67% of the recipients accepted the kidney from a donor with a similar haplotype, compared to none without medication. This matters because it suggests that using CsA could improve success rates for kidney transplants between family members, which often involves matching only certain genetic markers. Who this helps: This helps patients receiving kidney transplants from family members.

Plain English
This study looked at how a drug called cyclosporin A helps miniature swine accept kidney transplants without their bodies rejecting them. Researchers found that when swine received cyclosporin A, they tolerated the transplants 100% of the time, while those not receiving it rejected their transplants within two weeks. They also discovered that giving a substance called IL-2, which boosts T cell activity, led to rejection of the transplant in all cases where it was administered shortly after the surgery, showing that initial limited T cell activity is crucial for long-term acceptance of the transplant. Who this helps: This helps patients needing kidney transplants by improving transplant survival rates.

Plain English
This study focused on nine patients who had ten aneurysms in the branches of the celiac trunk, an important blood vessel in the abdomen. The researchers diagnosed these conditions using advanced imaging techniques and found that while most patients underwent surgery to repair the aneurysms, one patient with pancreatic cancer could not be operated on. None of the treated patients died during hospital stays, and they enjoyed excellent outcomes over five years. Who this helps: This research benefits patients with vascular conditions, particularly those with aneurysms in the celiac trunk branches.

Plain English
This study looked at 103 patients who had surgery to remove parts of their pancreas and nearby organs between 1968 and 1981. It found that 43.7% of these surgeries were for non-cancer issues, while 56.3% were for cancer, with a hospital death rate of 10.6% overall, and 8.3% for planned surgeries. The study highlighted that older patients over 65, those with urgent surgery needs, and those with kidney problems had higher risks of complications and death, making careful evaluation of these factors crucial before deciding on surgery. Who this helps: This information benefits doctors making decisions about surgery for pancreatic issues and helps them identify higher-risk patients.